ATE260282T1 - Aromatische ester von camptothecinen und verfahren zur behandlung von krebserkrankungen - Google Patents

Aromatische ester von camptothecinen und verfahren zur behandlung von krebserkrankungen

Info

Publication number
ATE260282T1
ATE260282T1 AT00950619T AT00950619T ATE260282T1 AT E260282 T1 ATE260282 T1 AT E260282T1 AT 00950619 T AT00950619 T AT 00950619T AT 00950619 T AT00950619 T AT 00950619T AT E260282 T1 ATE260282 T1 AT E260282T1
Authority
AT
Austria
Prior art keywords
camptothecines
treatment
cancer diseases
aromatic esters
compounds
Prior art date
Application number
AT00950619T
Other languages
English (en)
Inventor
Zhisong Cao
Beppino C Giovanella
Original Assignee
Stehlin Foundation For Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stehlin Foundation For Cancer filed Critical Stehlin Foundation For Cancer
Application granted granted Critical
Publication of ATE260282T1 publication Critical patent/ATE260282T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00950619T 1999-08-03 2000-07-25 Aromatische ester von camptothecinen und verfahren zur behandlung von krebserkrankungen ATE260282T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/365,633 US6228855B1 (en) 1999-08-03 1999-08-03 Aromatic esters of camptothecins and methods to treat cancers
PCT/US2000/020133 WO2001009139A1 (en) 1999-08-03 2000-07-25 Aromatic esters of camptothecins and methods to treat cancers

Publications (1)

Publication Number Publication Date
ATE260282T1 true ATE260282T1 (de) 2004-03-15

Family

ID=23439682

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00950619T ATE260282T1 (de) 1999-08-03 2000-07-25 Aromatische ester von camptothecinen und verfahren zur behandlung von krebserkrankungen

Country Status (9)

Country Link
US (2) US6228855B1 (de)
EP (1) EP1200443B1 (de)
JP (1) JP5301066B2 (de)
AT (1) ATE260282T1 (de)
AU (1) AU6369900A (de)
CA (1) CA2380022C (de)
DE (1) DE60008540T2 (de)
ES (1) ES2213593T3 (de)
WO (1) WO2001009139A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1037649B1 (de) 1997-12-17 2009-09-30 Enzon, Inc. Polymere vorstufenwirkstoffe von amino-und hydroxyl-enthaltenden bioaktiven agentien
US6509027B2 (en) 2001-02-12 2003-01-21 Supergen, Inc. Injectable pharmaceutical composition comprising coated particles of camptothecin
US6497896B2 (en) 2001-02-12 2002-12-24 Supergen, Inc. Method for administering camptothecins via injection of a pharmaceutical composition comprising microdroplets containing a camptothecin
US6534080B2 (en) 2001-02-12 2003-03-18 Super Gen, Inc. Method for administering camptothecins via injection of pharmaceutical composition comprising coated particles of a camptothecin
US20020150615A1 (en) * 2001-02-12 2002-10-17 Howard Sands Injectable pharmaceutical composition comprising microdroplets of a camptothecin
US6703399B2 (en) * 2002-05-06 2004-03-09 The Stehlin Foundation For Cancer Research Halo-alkyl esters of camptothecins and methods of treating cancer using these compounds
US6699875B2 (en) * 2002-05-06 2004-03-02 The Stehlin Foundation For Cancer Research Cascade esters of camptothecins and methods of treating cancer using these compounds
ITRM20020306A1 (it) 2002-05-31 2003-12-01 Sigma Tau Ind Farmaceuti Esteri in posizione 20 di camptotecine.
CN100443486C (zh) * 2002-09-11 2008-12-17 中国医学科学院药物研究所 7-酯化和7,20-双酯化的喜树碱衍生物及其制法和其药物组合物与用途
US20040204435A1 (en) * 2003-04-09 2004-10-14 Joachim Liehr Alternating treatment with topoisomerase I and topoisomerase II inhibitors
WO2005062985A2 (en) * 2003-12-23 2005-07-14 American Bioscience, Inc. Di-ester prodrugs of camptothecin, process for their preparation and their therapeutical applications
WO2005062991A2 (en) * 2003-12-23 2005-07-14 American Bioscience, Inc. Ten and 20-di-esterification derivatives of camptothecins and methods to treat cancers
WO2005070936A1 (en) * 2004-01-09 2005-08-04 Institute Of Mataria Medica, Chinese Academy Of Medical Sciences 20-esterized camptothecin derivatives, their preparation and the pharmaceutical compositions and the use
US20060135546A1 (en) * 2004-12-16 2006-06-22 Jagadevappa Basavaraja Methods for the purification of 20(S)- camptothecin
US7875602B2 (en) * 2005-10-21 2011-01-25 Sutter West Bay Hospitals Camptothecin derivatives as chemoradiosensitizing agents
US7928235B2 (en) * 2006-08-11 2011-04-19 The Christus Stehlin Foundation For Cancer Research Methods of making esters of camptothecins
US7572803B2 (en) * 2007-10-25 2009-08-11 The Christus Stehlin Foundation For Cancer Research Hydrated crystalline esters of camptothecin
US20130121921A1 (en) 2011-11-11 2013-05-16 The Christus Stehlin Foundation For Cancer Research Rodent Therapeutic Model And Methods
CN115073483B (zh) * 2022-07-27 2022-10-25 泽升科技(广州)有限公司 一种伊立替康的对映体的制备方法

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3894029A (en) 1971-08-26 1975-07-08 Basf Ag Production of camptothecin and camptothecin-like compounds
US4399282A (en) 1979-07-10 1983-08-16 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives
JPS56108787A (en) 1980-01-31 1981-08-28 Sato Yakugaku Kenkyusho:Kk Camptothecin coline salt and its preparation
US4473692A (en) * 1981-09-04 1984-09-25 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives and process for preparing same
JPS6019790A (ja) * 1983-07-14 1985-01-31 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体
US4894456A (en) 1987-03-31 1990-01-16 Research Triangle Institute Synthesis of camptothecin and analogs thereof
US5227380A (en) * 1987-03-31 1993-07-13 Research Triangle Institute Pharmaceutical compositions and methods employing camptothecins
US5053512A (en) 1987-04-14 1991-10-01 Research Triangle Institute Total synthesis of 20(S) and 20(R)-camptothecin and compthothecin derivatives
US5106742A (en) 1987-03-31 1992-04-21 Wall Monroe E Camptothecin analogs as potent inhibitors of topoisomerase I
US5180722A (en) 1987-04-14 1993-01-19 Research Triangle Institute 10,11-methylenedioxy-20(RS)-camptothecin and 10,11-methylenedioxy-20(S)-camptothecin analogs
CA1332413C (en) 1987-06-25 1994-10-11 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives and process for preparing same
JPS6461482A (en) 1987-08-31 1989-03-08 Yakult Honsha Kk Dehydrocamptothecin and production thereof
US4943579A (en) 1987-10-06 1990-07-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble prodrugs of camptothecin
US5225404A (en) 1989-11-06 1993-07-06 New York University Methods of treating colon tumors with tumor-inhibiting camptothecin compounds
US5552154A (en) 1989-11-06 1996-09-03 The Stehlin Foundation For Cancer Research Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof
JP2848958B2 (ja) 1990-09-28 1999-01-20 スミスクライン・ビーチャム・コーポレイション 水溶性カンプトテシン類似体、方法および手段
US5126351A (en) 1991-01-24 1992-06-30 Glaxo Inc. Antitumor compounds
ES2187500T3 (es) 1991-02-21 2003-06-16 Smithkline Beecham Corp Uso de topotecano en el tratamiento del carcinoma pulmonar no de celulas pequeñas.
US5391745A (en) 1992-07-23 1995-02-21 Sloan-Kettering Institute For Cancer Research Methods of preparation of camptothecin analogs
CA2146126A1 (en) 1992-10-07 1994-04-14 Kenji Irie Pharmaceutical compositions for inhibiting the formation of tumor necrosis factor
US5552156A (en) 1992-10-23 1996-09-03 Ohio State University Liposomal and micellular stabilization of camptothecin drugs
FR2697752B1 (fr) 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
EP0602361B1 (de) 1992-11-17 1997-01-22 C. Rob. Hammerstein GmbH Rückenlehnengelenk für einen Fahrzeugsitz
US5352789A (en) 1993-02-25 1994-10-04 The Stehlin Foundation For Cancer Research Methods for purifying camptothecin compounds
US5527913A (en) 1993-02-25 1996-06-18 The Stehlin Foundation For Cancer Research Methods for purifying camptothecin compounds
US5880131A (en) 1993-10-20 1999-03-09 Enzon, Inc. High molecular weight polymer-based prodrugs
US5840900A (en) 1993-10-20 1998-11-24 Enzon, Inc. High molecular weight polymer-based prodrugs
GB9402934D0 (en) 1994-02-16 1994-04-06 Erba Carlo Spa Camptothecin derivatives and process for their preparation
GB9410388D0 (en) 1994-05-24 1994-07-13 Erba Carlo Spa Method for the preparation of 9-amino camptothecin
US5786344A (en) 1994-07-05 1998-07-28 Arch Development Corporation Camptothecin drug combinations and methods with reduced side effects
US5646159A (en) 1994-07-20 1997-07-08 Research Triangle Institute Water-soluble esters of camptothecin compounds
US5736156A (en) 1995-03-22 1998-04-07 The Ohio State University Liposomal anf micellular stabilization of camptothecin drugs
US5834012A (en) 1995-05-03 1998-11-10 Roman Perez-Soler Lipid complexed topoisomerase I inhibitors
GB9510716D0 (en) 1995-05-26 1995-07-19 Pharmacia Spa Substituted camptothecin derivatives and process for their preparation
US5726181A (en) 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
SG50747A1 (en) 1995-08-02 1998-07-20 Tanabe Seiyaku Co Comptothecin derivatives
CA2192725C (en) 1995-12-28 2004-04-20 Kenji Tsujihara Camptothecin derivatives
US5731316A (en) 1996-01-30 1998-03-24 The Stehlin Foundation For Cancer Research Derivatives of camptothecin and methods of treating cancer using these derivatives
AU718799C (en) 1996-08-19 2004-02-12 Bionumerik Pharmaceuticals, Inc. Highly lipophilic camptothecin derivatives
US5827533A (en) 1997-02-06 1998-10-27 Duke University Liposomes containing active agents aggregated with lipid surfactants
US6111107A (en) * 1997-11-20 2000-08-29 Enzon, Inc. High yield method for stereoselective acylation of tertiary alcohols

Also Published As

Publication number Publication date
EP1200443A1 (de) 2002-05-02
EP1200443B1 (de) 2004-02-25
AU6369900A (en) 2001-02-19
JP5301066B2 (ja) 2013-09-25
WO2001009139A1 (en) 2001-02-08
US20020049324A1 (en) 2002-04-25
JP2003506378A (ja) 2003-02-18
US6228855B1 (en) 2001-05-08
US6407239B1 (en) 2002-06-18
CA2380022C (en) 2010-10-19
DE60008540D1 (de) 2004-04-01
ES2213593T3 (es) 2004-09-01
CA2380022A1 (en) 2001-02-08
DE60008540T2 (de) 2004-07-29

Similar Documents

Publication Publication Date Title
ATE260282T1 (de) Aromatische ester von camptothecinen und verfahren zur behandlung von krebserkrankungen
DE69830072D1 (de) Radioaktive zusammensetzungen zur behandlung von prostatatumoren
DE60029799D1 (de) Verbindungen, verfahren und pharmazeutische zubereitungen zur behandlung von zellschäden wie zum beispiel schäden an nerven- oder kerzgefässgewebe
DE60105295D1 (de) Chinazolinderivate zur behandlung von tumoren
DE60021381D1 (de) Chinonverbindungen zur behandlung von krankheiten
DE60032795D1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
MX9803851A (es) Compuestos macrociclicos novedosos como inhibidores de metaloproteasas.
DE60112766D1 (de) Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen
ATE485818T1 (de) Zusammensetzungen aus ezetimib und verfahren zur behandlung von mit cholesterin zusammenhängenden gutartigen und bösartigen tumoren
DE60136748D1 (de) Verfahren und zusammensetzungen zur behandlung von augenerkrankungen
DE60035693D1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
DE602004028574D1 (de) Zusammensetzungen und verfahren zur behandlung des reizdarmsyndroms und von nichtulzeröser dyspepsie
DE3854121D1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
ATE281841T1 (de) Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen
DE60005952T8 (de) Lösliche hla-g enthaltende zusammensetzungen zur behandlung entzündlicher hautkrankheiten
ATE262330T1 (de) Verwendung eines nitroxids oder seiner prodrugs zur prophylaktischen und therapeutischen behandlung von krebs
DE69818809D1 (de) Verfahren zur behandlung von narbengewebe
DE60023555D1 (de) Verfahren zur behandlung von gewebe
ATE315387T1 (de) Verwendung von substituierten 6- dimethylaminomethyl-1-phenyl- cyclohexanverbindungen zur therapie der harninkontinenz
EP1233978A4 (de) Zusammensetzungen und verfahren zur verbesserten diagose und behandlung keimzellentumoren
DE60334289D1 (de) Dithiolopyrrolon-derivate zur behandlung von proliferativen störungen
ATE271384T1 (de) Arylnitron therapeutische mittel zur behandlung von entzündlichen darmerkrankungen
ATE419348T1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
EP1178814A4 (de) Verfahren zur identifizierung von therapeutischen zusammensetzungen zur behandlung von leberstörungen
DE60305520D1 (de) 2" oxo-voruscharin und derivaten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties